North Dakota State University
Bioprinting of Pancreatic Cancer Cells for Improved Drug Testing
Abstract
dc:description.abstractCurrently, many drugs are preclinically tested on two-dimensional cell cultures. However, this method does not adequately replicate the cellular interactions or diffusion gradient that occur in three-dimensional tissues, leading to poor indicators of how a drug may affect human tissues. The objective of this project was to use bioprinted pancreatic cancer cell cultures as a platform for three-dimensional drug testing. Various bioink formulations of cellulose, gelatin, and alginate were evaluated to determine which provided the best printability and cell viability. A cellulose nanocrystal and alginate hydrogel showed superior printability due to its shear thinning properties. Additionally, initial cell viability was nearly 80%, and it remained above 60% over four days. Use of a custom spinning bioreactor at 50 rpm resulted in no improvements to cell viability. Overall, the system shows potential as a drug testing platform to evaluate the effectiveness of various drug formulations on three-dimensional pancreatic cancer cell cultures.
Degree
thesis:*- Grantor dc:publisher
- North Dakota State University
- Year dc:date.issued
- 2019
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Rehovsky, Chad Austin
Subjects
dc:subject × 4Rights
dc:rights- Statement dc:rights
-
- NDSU policy 190.6.2
- Licence dc:rights.uri
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/10365/31696